TrialClinical pharmacokinetics2018

Population Pharmacokinetic Modeling of Olaratumab, an Anti-PDGFRα Human Monoclonal Antibody, in Patients with Advanced and/or Metastatic Cancer.

Gary Mo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.